Oncologist encouraged by cancer advance. Dr. Blachly steps up the case for breast cancer screening.
Marshall
E
E
D000911:Antibodies, Monoclonal / Q000627:therapeutic use; D061067:Antibodies, Monoclonal, Humanized; D000970:Antineoplastic Agents / Q000627:therapeutic use; D001131:Arkansas; D001943:Breast Neoplasms / Q000517:prevention & control* / Q000628:therapy; D005260:Female; D049673:History, 20th Century; D006801:Humans; D008495:Medical Oncology; D018719:Erb-b2 Receptor Tyrosine Kinases; D012106:Research; D000068878:Trastuzumab
D000911:Antibodies, Monoclonal; D061067:Antibodies, Monoclonal, Humanized; D000970:Antineoplastic Agents; D018719:Erb-b2 Receptor Tyrosine Kinases; D000068878:Trastuzumab